Sean Maass

Title: The Innovative Mind of Sean Maass: Pioneering Intraocular Drug Delivery Systems

Introduction

Sean Maass is an inventive figure based in Aliso Viejo, California, recognized for his contributions to the field of intraocular medical technology. With a total of two patents to his name, he has focused on developing systems that enhance drug delivery to the eye, demonstrating his commitment to improving patient care through innovation.

Latest Patents

Sean Maass is the inventor behind two notable patents in the realm of intraocular lens (IOL) assemblies. The first patent, titled "Systems to affix devices to intraocular lens assemblies and related methods," introduces systems and methods for effectively securing a drug delivery component to an IOL assembly. This innovation includes a support base designed to hold the drug delivery device and a plunger guide, allowing the plunger to interact with both the drug delivery component and the IOL assembly. The clever design of the plunger's tip, featuring a ramp for fixation, enhances the efficiency of drug delivery during use.

His second patent, "Stabilized intraocular drug delivery systems and methods of use," provides a stabilized drug delivery system intended for implantation within a subject's eye. This system comprises an IOL assembly complete with a lens and haptic section, coupled with a drug delivery component containing at least one therapeutic agent. The system's design ensures secure attachment of the drug delivery component to the IOL assembly, promoting stability and preventing unwanted movement.

Career Highlights

Sean's professional journey encompasses significant contributions at various organizations. He has worked with Spyglass Pharma, Inc., a company focusing on innovative pharmaceutical developments, and the University of Colorado, where he collaborated with top researchers in medical technology. His work has consistently aimed at bridging the gap between innovative engineering and practical medical solutions.

Collaborations

Throughout his career, Sean Maass has collaborated with esteemed professionals in the medical field, including Craig Alan Cable II and Malik Y Kahook. These partnerships have undoubtedly enhanced his research efforts and contributed to the advancements in ocular drug delivery systems.

Conclusion

Sean Maass stands as a testament to the impact that innovative thinking can have on the medical field. His patents address critical needs in drug delivery systems and highlight the importance of ongoing research and collaboration in advancing medical technologies. Through his work, Sean continues to push the boundaries of what is possible in intraocular treatments, making significant strides towards improving patient outcomes.